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Abstract
Background: Excessive production of free radicals has been implicated in many diseases including cancer.
They are highly reactive and bring about oxidation of biomolecules i.e., proteins, lipids and nucleic acids which
are associated with many degenerative diseases. Natural products acting as antioxidants have ability to neutralize
free radicals and their actions and hence they mitigate their harmful effects. The present study was designed
to investigate pharmacological properties viz., antioxidant, antibacterial and antiproliferative activities of
cinnamaldehyde and eugenol, the two naturally occurring phenylpropanoids present in Cinnamomum spp.
and other plants.
Methods: The antioxidant potential of test compounds was evaluated by measuring DPPH free radical scavenging,
reducing power and metal ion chelating activities. Protection against membrane damage was assayed by inhibition
of lipid peroxidation in rat liver homogenate. Antibacterial activity was measured by Kirby-Bauer disc diffusion
method while antiproliferative activity of test compounds was measured by sulforhodamine-B (SRB) assay.
Results: Eugenol exhibited noticeable antioxidant potential in DPPH radical scavenging (81 %) and reducing power
(1.12) assays at 1.0 μM/ml and 0.1 μM/ml concentrations, respectively. IC50 value of eugenol for radical scavenging
activity was found to be 0.495 μM/ml. Cinnamaldehyde demonstrated considerable metal ion chelating ability
(75 %) at 50 μM/ml and moderate lipo-protective activity in lipid peroxidation assay at 3 μM/ml. In addition
cinnamaldehyde also showed appreciable antibacterial activity (zone of inhibition 32–42 mm) against Bacillus cereus
(MTCC 6840), Streptococcus mutans (MTCC 497), Proteus vulgaris (MTCC 7299), Salmonella typhi (MTCC 3917) and
Bordetella bronchiseptica (MTCC 6838) while eugenol produced moderate activity at 80 μM/disc. Cinnamaldehyde
exhibited comparatively better antiproliferative potential against breast (T47D) and lung (NCI-H322) cancer cell lines
than eugenol in SRB assay at 50 μM concentration.
Conclusion: Cinnamaldehyde possessed metal ion chelating, lipo-protective, antibacterial and antiproliferative
activities while eugenol showed potent H-atom donating potential indicating radical quenching and reducing
power abilities. Medicinal attributes shown by both the compounds indicated their usefulness in food and
pharmaceutical sector.
Keywords: Cinnamaldehyde, Eugenol, Phenylpropanoid, Free radical, Antioxidant, Antibacterial, Antiproliferative,
Lipoprotective
* Correspondence: akpandey23@rediffmail.com
Department of Biochemistry, University of Allahabad, Allahabad 211002, India
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sharma et al. BMC Complementary and Alternative Medicine  (2016) 16:156 
DOI 10.1186/s12906-016-1147-4
Background
Free radicals are associated with many degenerative dis-
eases including cancer, cardio-vascular diseases, cataract,
immune system decline and brain dysfunction [1]. Under
normal metabolic conditions about 2–5 % of O2 consumed
by mitochondria is converted to ROS (Reactive oxygen
species) during metabolic process within the body [2].
Their excessive production during abnormal conditions is
regulated naturally by antioxidant system [3]. Failure of
antioxidant defenses results in a pathophysiological condi-
tion known as oxidative stress. Highly active oxygen and
nitrogen species (ROS and RNS) are generally considered
to be markers of oxidative stress. They permanently
modify the genetic material leading to numerous
degenerative or chronic diseases [4]. Mis-repair of
DNA damage results in mutations such as base substitu-
tion and deletion which lead to carcinogenesis [5].
Antioxidants are a group of substances which are either
produced in situ or supplied through food and supple-
ments. They protect free radical mediated membrane
damage because of their scavenging and chelating proper-
ties [6, 7]. Butylated hydroxyanisole (BHA) and butylated
hydroxytoluene (BHT) are commonly used as synthetic
antioxidant but their uses are restricted by legislative rules
because of doubts over their toxic and carcinogenic effects
[8]. Antioxidants derived from plants are presumed to be
safe since they are natural in origin and have capability to
counteract the damaging effect of ROS [9].
Many microorganisms cause food spoilage which is
one of the most important concerns of the food industry
[10]. Initially, synthetic chemicals were used to prevent
microbial contamination as well as oxidation of dietary
components so that they remained in their natural form.
Because of the growing concern of consumer about the
side effects of synthetic compounds and want of safer
material for preventing and controlling pathogenic mi-
croorganisms in food, natural products are currently
being used to prevent microbial contamination [11].
Phytochemicals have been reported to modulate human
metabolism in a manner beneficial for the prevention of
infectious and degenerative diseases [12, 13].
Spices and aromatic vegetable material of natural origin
are used in food industries to enhance flavor and fragrance
qualities of food materials. Moreover they are also used as
traditional medicine [14]. Spices are good sources of nat-
ural antioxidant and antibacterial agents. Cinnamon and
bay leaf are used as spices and obtained from Cinnamo-
mum spp. Principle components like cinnamaldehyde, eu-
genol, cinnamic acid and cineol etc. are responsible for
the antioxidant activity in cinnamon [15]. Very low
amount of eugenol is usually present in cinnamon bark
but it is the major component of cinnamon leaf essential
oil. It is also abundantly present in Syzygium aromaticum
(clove). Both cinnamaldehyde and eugenol belong to phe-
nylpropanoid class of phytochemicals. Cinnamaldehyde
bears an aldehyde group on benzene ring via three carbon
chain while eugenol has one hydroxy and one methoxy
group which are directly attached to the ring (Fig. 1).
Eugenol has a wide range of application in perfumes,
flavorings, essential oils and in medicine as a local antisep-
tic and anesthetic [16]. Present study reports antioxidant,
antibacterial and antiproliferative activities of cinnamal-




Cinnamaldehyde (3-phenyl-2-propenal), eugenol (2-meth-
oxy-4-(2-propenyl) phenol), DPPH (2, 2-diphenyl-1-picryl
hydrazyl), tert-butyl-4-hydroxytoluene (BHT), butylated
hydroxyanisole (BHA) were obtained from Himedia, Pvt.
Ltd Mumbai, India.
Assessment of antioxidant ability by in vitro assays
Free radical (DPPH) scavenging assay
The hydrogen-donating ability of cinnamaldehyde and
eugenol was examined in the presence of DPPH, a
stable radical using the method of Singh et al. [17].
One ml cinnamaldehyde (0.4–4.0 mM/ml) and eugenol
(0.4–4.0 μM/ml) prepared in DMSO were taken in
different test tubes and 3 ml of 0.1 mM DPPH solution
prepared in methanol was added. The content was mixed
Fig. 1 Chemical structures of cinnamaldehyde (3-Phenyl-2-propenal) and eugenol (2-Methoxy-4-(2-propenyl) phenol)
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and allowed to stand at room temperature for 30 min in
dark. Final concentration of cinnamaldehyde and eugenol
in reaction mixture was 0.1–1.0 mM/ml and 0.1–1.0 μM/
ml, respectively. The reduction of DPPH free radical was
measured by recording the absorbance at 517 nm. BHA
was used as standard for comparison. Control tubes con-
tained 1 ml DMSO and 3 ml DPPH reagent in reaction
mixture. The radical scavenging activities (%) at different
concentrations of the test samples were calculated using
the following formula.
Free radical scavenging activity %ð Þ
¼ AC−ASð Þ=AC½   100
where AC and AS are the absorbance values of the con-
trol and the sample, respectively. IC50 value, the concen-
tration of sample exhibiting 50 % free radical scavenging
activity, was also determined by non-linear regression
analysis using GraphPad Prism software.
Reducing power assay
The reducing power of the sample was determined by
the method of Oyaizu [18]. DMSO was used as solvent
to make different concentrations of samples. 1.0 ml of
sample and standard was placed in different test tubes.
To each test tube 2.5 ml of phosphate buffer (0.2 M,
pH 6.6) and 2.5 ml of 1 % potassium hexa-cyanoferrate
(K3Fe(CN)6) were added and contents were vortexed.
Final concentration of cinnamaldehyde, eugenol and as-
corbic acid in reaction mixture was 0.02–0.1 μm/ml.
Tubes were then incubated at 50 °C in a water bath for
20 min. The reaction was stopped by adding 2.5 ml of
10 % TCA solution and then centrifuged at 4000 rpm
for 10 min. After centrifugation 1.0 ml of the super-
natant was mixed with 1 ml of distilled water and 0.5 ml
of ferric chloride solution (0.1 %, w/v) and kept at room
temperature for 2 min. The reaction led to formation of
greenish blue colour. The absorbance was measured at
700 nm and higher absorbance values denoted better
reducing power of the test samples. Ascorbic acid was
used as standard for comparison.
Lipid peroxidation inhibition activity (LPOI)
Lipo-protective efficacy of samples was estimated by the
method of Halliwell and Gutteridge [19]. The study was
performed in accordance with the Guide for the Care
and Use of Laboratory Animals, as promulgated by
CPCSEA India and adopted by Institutional Animal
Ethics Committee, University of Allahabad, Allahabad.
The liver tissue was isolated from normal albino Wistar
rats and 10 % (w/v) homogenate was prepared in phos-
phate buffer (0.1 M, pH 7.4 having 0.15 M KCl) using
homogenizer. The homogenate was centrifuged at 800 g
for 15 min and clear cell free supernatant was used for
in vitro lipid peroxidation inhibition assay. 100 μl of dif-
ferent concentrations of samples was taken in different
tubes, followed by addition of 1.0 ml KCl (0.15 M),
0.3 ml phosphate buffer and 0.5 ml of tissue homogen-
ate. Peroxidation was initiated by adding 100 μl FeCl3
(0.2 mM). Final concentration of cinnamaldehyde, eu-
genol and BHA (standard) in reaction mixture was
1.0–3.0 μM/ml. After incubation at 37 °C for 30 min, lipid
peroxidation was monitored by the formation of thiobar-
bituric acid reactive substances which were estimated
by adding 2 ml of ice-cold hydrochloric acid (0.25 N)
containing 15 % TCA, 38 % TBA and 0.5 % BHT.
The reaction mixture was incubated at 80 °C for 1 h
followed by cooling and centrifugation. The absorbance of
the pink supernatant was measured at 532 nm. All analyses
were carried out in triplicate and results were expressed as
mean ± SD. The protective effect of extracts against
lipid peroxidation (% LPOI) was calculated by using
the following formula.
LPOI %ð Þ ¼ Ac−Asð Þ=Ac½   100
where Ac is absorbance of control and As is absorbance
in the presence of the sample or standard compounds.
Metal ion chelating activity
The chelating activity of the cinnamaldehyde and eugenol
was measured by the method of Dinis et al. [20]. Samples
(200 μl) containing different concentrations were prepared
in methanol followed by addition of 50 μl of FeCl2
(2.0 mM). The reaction was initiated by addition of 200 μl
of 50 mM ferrozine and the reaction mixture was shaken
vigorously and left standing at room temperature for
10 min. Concentration of cinnamaldehyde and eugenol in
final reaction mixture was 5–50 μM/ml. After the mixture
had reached equilibrium, the absorbance of the pink violet
colour solution was measured spectrophotometrically at
562 nm by using a UV-Visible spectrophotometer (Visis-
can 067). BHA and EDTA were used for comparison. The
control contained FeCl2 and ferrozine, without samples.
The percentage inhibition of ferrozine-Fe2+ complex for-
mation was measured in form of metal chelating activity.
%Metal ion chelating activity ¼ Ac−Asð Þ=Ac½   100
where Ac is absorbance of control and As is absorbance
in the presence of the sample or standard compounds.
Antibacterial activity assessment
Bacterial strains
Gram negative [Proteus vulgaris (MTCC 7299), Salmon-
ella typhi (MTCC 3917) and Bordetella bronchiseptica
(MTCC 6838)] and Gram positive [Bacillus cereus (MTCC
6840) and Streptococcus mutans (MTCC 497)] bacteria
were obtained from IMTECH, Chandigarh, India.
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Disc diffusion method for antimicrobial activity assay
Antimicrobial activity of each plant extract was determined
using Kirby-Bauer disc diffusion method [21]. Briefly,
100 μl of the test bacteria was inoculated in 10 ml of fresh
nutrient media until they reached a count of approximately
108cells/ml. From the log phase culture, 100 μl of the
microbial suspension was spread onto Muller Hinton agar
plates. Sterile discs (diameter 6 mm, Hi Media) were im-
pregnated with 20 μl of the test sample, and placed onto
inoculated plates followed by incubation at 37 °C for 24 h.
Standard antibiotic discs (Meropenem 10 μg and vanco-
mycin 30 μg) were used as control. Diameter of the inhib-
ition zones were measured in millimeters (mm) and results
were reported as average of three replicates.
Evaluation of antiproliferative activity by SRB assay
The in vitro antiproliferative activity of test compounds
was determined using sulforhodamine-B dye (SRB) assay
[22]. Cell suspension (100 μl, 1 × 105 to 2 × 105 cells per
ml depending upon mass doubling time of cells) was
grown in 96-well tissue culture plate and incubated for
24 h. Stock solutions of test compounds were prepared
in DMSO and serially diluted with growth medium to
obtain desired concentrations. 100 μl samples (100 μM)
were then added to the wells and cells were further incu-
bated for another 48 h. The cell growth was arrested by
layering 50 μl of 50 % TCA and incubated at 40 °C for
an hour followed by washing with distilled water and
then air-dried. SRB (100 μl, 0.4 % in 1 % acetic acid) was
added to each well and plates were incubated at room
temperature for 30 min. The unbound SRB dye was
washed with 1 % acetic acid and then plates were air
dried. Tris–HCl buffer (100 μl, 0.01 M, pH 10.4) was
added and the absorbance was recorded on ELISA
reader at 540 nm. Each test was done in triplicate. The
values are reported as mean ± SD of three replicates.
Statistical analysis
All experiments were carried out in triplicate and data
were represented as mean ± standard deviation (SD).
Graphs were prepared using GraphPad Prism software.
Data were analyzed using One-way ANOVA and the values
of P <0.05 were considered as statistically significant.
Results
DPPH free radical scavenging assay
Radical scavenging potential of compounds was deter-
mined by measuring the degree of discoloration of DPPH
solution. Eugenol exhibited strong antioxidant potential
(58–81 %) at all test concentrations (0.25–1.0 μM/ml)
while cinnamaldehyde showed lower to moderate radical
scavenging ability (23–57 %) (Fig. 2). The DPPH radical
scavenging potential of eugenol was comparable to the ac-
tivity shown by the standard antioxidant BHA (62–82 %).
IC50 value for eugenol and cinnamaldehyde were found to
be 0.495 μM/ml and 0.842 mM/ml, respectively.
Reducing power assay
Reducing power ability of test compounds exhibited the
similar pattern as observed in radical scavenging assay.
Eugenol showed appreciable reducing ability (absorbance
0.33–1.12) as compared to cinnamaldehyde (0.20–0.62)
in the concentration range 0.02–0.1 μM/ml (Fig. 3).
However ascorbic acid accounted for slightly higher re-
ducing power (0.36–1.58). Cinnamaldehyde and eugenol
exhibited about 55 and 92 % reducing power of ascorbic
acid, respectively, at lower concentration (0.02 μM/ml)
while at higher concentration (0.1 μM/ml) they showed
40 and 71 % activity of ascorbic acid, respectively.
Lipid peroxidation inhibition activity
Cinnamaldehyde and eugenol mediated protective ef-
fect on metal induced lipid peroxidation was measured
in liver homogenate of albino Wistar rats in vitro and is
represented as % LPOI (lipid peroxidation inhibition).
Test compounds exhibited low to moderate activity.
Cinnamaldehyde showed comparatively better protect-
ive action (LPOI 11–33 %) against peroxidative damage
in the concentration range 1–3 μM/ml (Fig. 4). Under
same test conditions eugenol accounted for lower activ-
ity (LPOI 5–15 %). BHA was used for comparison,
which produced 18–56 % lipoprotective activity.
Malondialdehyde produced by lipid peroxidation forms a
pink chromogenic substance after reaction with thio-
barbituric acid (TBA) which makes the basis for this
measurement.
Metal ion chelating activity
Cinnamaldehyde showed better chelating ability as
compared to eugenol at all test concentrations (Fig. 5).
BHA and EDTA were used as standard chelating agents
for comparison. Cinnamaldehyde exhibited about 45–
75 % metal ion chelating ability in the concentration
range 5–50 μM/ml which is equivalent to 59–78 %
and 90–98 % of the activities demonstrated by EDTA
and BHA, respectively (Fig. 5). Similarly eugenol produced
41–60 % activity (EDTA equivalent) and 68–73 %
(BHA equivalent).
Antibacterial activity
Bacteria used in the study showed susceptibility to test
samples (Table 1). Cinnamaldehyde exhibited remarkable
activity against both Gram positive [B. cereus (MTCC
6840), Streptococcus mutant (MTCC 497)] and Gram
negative [P. vulgaris (MTCC7299), S. typhi (MTCC 3917),
B. bronchiseptica (MTCC 6838)] bacteria. Concentration
dependent response was observed in the activity
pattern. At 20 μM/disc inhibition zones produced by
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cinnamaldehyde ranged between 22 and 30 mm
while at concentration 80 μM/disc appreciable activ-
ity was observed (inhibition zones 32–40 mm). How-
ever saturation effect was observed at further higher
concentration (120 μM/disc). Eugenol in general
showed lower to moderate response (inhibition zones
9–18 mm) at test concentrations. Meropenem and
vancomycin exhibited 18–27 mm zone of inhibition
against test bacteria. Results indicated that cinnamalde-
hyde has potent antibacterial activity.
Evaluation of antiproliferative activity
Moderate antiproliferative activity (43–46 %) was ob-
served with cinnamaldehyde against breast (T47D) and
lung (NCI-H322) cancer cell lines at 50 μM concentra-
tion while very low activity was observed against pros-
tate (PC-3) cancer cell line at the same concentration in
SRB assay (Fig. 6). In comparison to cinnamaldehyde,
eugenol exhibited lower activity viz., 39, 17 and 13 %
against T47D, NCIH-322 and PC-3 cell lines, respectively.
Standard anticancer drugs mitomycin (1 μM) used against
breast and prostate cancer cell lines and 5-Flurouracil
(5 μM) used against lung cancer cell line showed 50–60 %
antiproliferative activity only.
Discussion
Plants are natural repositories of molecules with diverse
structural and functional attributes. Many phytoconstitu-
ents exhibit nutritive and pharmacological activities
[23–25]. They interact with different molecular and cellu-
lar targets including enzymes, hormones, trans-membrane
transporters, and neurotransmitter receptors [26, 27].
Number of plant species and their metabolites have been
identified and studied for their use in the pharmaceutical,
medical, and agricultural industries [28]. Current work
reports the biological activities of cinnamaldehyde and eu-
genol, the two phenylpropanoids, which are abundantly
available in cinnamon and clove oils. Cinnamaldehyde
occurs naturally in the bark of Cinnamomum zeylani-
cum, C. cassia and C. camphora. Essential oil of cinna-
mon bark contains about 80 % cinnamaldehyde and
10 % eugenol while cinnamon leaf oil contains 5 %
cinnamaldehyde and about 95 % eugenol [29]. Eugenol
is also present in essential oil fractions of S. aromati-
cum, Myristica fragrans and Ocimum basilicum. About
80–90 % eugenol is present in essential oils obtained
from clove bud and leaf [30].
Free radicals play important role in the development
of many chronic diseases including heart disease, cancer
Fig. 2 DPPH free radical scavenging ability of cinnamaldehyde (Cin) and eugenol (Eug). Results are shown as mean ± SD of three replicates (P <0.05).
Concentrations are expressed as mM/ml (Cin) and μM/ml (Eug and BHA)
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and the aging process [31]. To counteract their adverse
effects‚ scavenging or reducing the formation of free rad-
icals in the body becomes significant for health. In the
present study cinnamaldehyde and eugenol have shown
capability to scavenge free radical in DPPH radical scav-
enging assay (Fig. 2). DPPH is a stable nitrogen centered
free radical and its color changes from violet to yellow
upon uptake of hydrogen or electrons [32]. The effect of
cinnamaldehyde and eugenol on DPPH is thought to be
due to their hydrogen donating ability. Eugenol demon-
strated greater radical scavenging activity as compared to
cinnamaldehyde because it easily donates hydrogen atom
of hydroxyl (OH) moiety directly linked to benzene ring
[33]. Radical scavenging activity of the compounds depends
on number and position of hydroxyl groups on aromatic
ring of phenolic compounds and therefore they show
ability to reduce the free radical level [25, 34]. Radical
scavenging action of eugenol is further supported by the
work of Mathew and Emilia [35]. They reported that
eugenol exhibited a faster reaction rate and stronger inten-
sities of white-yellow spots on thin layer chromatography
(TLC) plates as compared to cinnamaldehyde and cinna-
mon bark extract [35]. Our results have shown better rad-
ical scavenging activity of eugenol (IC50 value 0.495 μM/
ml) as compared with the report of Tominaga et al. [36].
Reducing power of bioactive compounds is often used
as an indicator of electron donating activity, which is an
important mechanism of antioxidant action [37]. Antiox-
idants can be reductants which inactivate oxidants. The
reducing ability is measured by the direct reduction of
ferricyanide (Fe3+) to ferrocyanide (Fe2+) which makes a
Perl’s Prussian blue complex after addition of FeCl3 and
absorbance is monitored at 700 nm. Increasing absorb-
ance indicates an increase in reducing ability. The experi-
mental data obtained in the current work indicated
remarkable reducing potential in eugenol as compared to
cinnamaldehyde (Fig. 3). Comparatively higher reducing
power of eugenol might be due to the di and mono hy-
droxyl substitutions in the aromatic ring, which possess
potent hydrogen or electron donating abilities [33, 38].
The process of lipid peroxidation, a free radical medi-
ated chain reaction, is related to injury and inflammation
and often associated with oxidative damage of membrane
lipids [39]. It is usually initiated by hydroxyl radical which
is produced through Fenton reaction in presence of metal
ion (Fe2+) [40]. Lipid peroxidation may be enzymatic and
non-enzymatic or both. Non enzymatic reaction involves
three phases namely, initiation, propagation and termin-
ation [41]. Lipid, lipoperoxyl, lipid hydro-peroxide, peroxyl
and alcoxyl radicals produced in the first two phases of
Fig. 3 Reducing power ability of cinnamaldehyde and eugenol. Reducing power and concentration of compounds are expressed as absorbance
and μM/ml, respectively. Ascorbic acid was used as standard reducing agent for comparison. Results are shown as mean ± SD (n = 3, P <0.05).
Abbreviations: Cin- cinnamaldehyde, Eug-eugenol and Asc- ascorbic acid
Sharma et al. BMC Complementary and Alternative Medicine  (2016) 16:156 Page 6 of 11
lipid peroxidation are harmful to the body. Malondialde-
hyde (MDA) is an important product of lipid peroxidation
which reacts with thiobarbituric acid (TBA) to form TBA-
MDA adduct with an absorption maxima at 532 nm [42].
In the study cinnamaldehyde accounted for 33 % reduc-
tion in adduct formation at 3 μM/ml concentration signi-
fying its lipoprotective action while lower activity was
shown by eugenol (Fig. 4). Protective activity shown by
test compounds could be attributed to the chelation of
metal ion (Fe3+) which is responsible for generation
of hydroxyl radical [43]. The antioxidants are believed
to intercept the free radical chain of oxidation and donate
hydrogen from the phenolic hydroxyl groups, thereby
forming a stable end product that does not initiate or
propagate further oxidation of lipid.
Transition metals catalyze the formation of the free
radicals which initiate and propagate chain reaction in
lipid peroxidation. Metal chelating capability indicates
efficiency of a compound to protect lipids against oxida-
tive damage [31]. Metal ions are quantitatively measured
by ferrozine which make complexes with Fe2+ and gives
pink colour. In the presence of chelating agents, the
complex formation is disrupted with the result that the
pink-red color of the complex is decreased. It has been
reported that chelating agents act as a secondary antioxi-
dants and form bonds with a metal because they reduce
the redox potential, thereby stabilizing the oxidized form
of the metal ion [44].
The present study reports that cinnamaldehyde has
greater ion chelating ability as compared to eugenol
(Fig. 5). This could be substantiated by the fact that aro-
matic aldehydes, especially with an effective conjugation
system, form stable Schiff bases which are generally bi-,
tri- or tetra- dentate chelate ligands and easily react with
almost all transition metal ions and form very stable
complexes with them. [45]. Moreover eugenol with the
meta-methoxy groups and with the olefinic bond far
away is not (well) suited for chelation (Fig. 1). This in
contrast to that of cis-cinnamaldehyde, which forms
chelates readily with low valent transition metals via pi-
bonding of C = C and C =O bonds or via bonding of its
C = C bond and the lone pair of C =O. Chelation reduces
polarity of metal ion because of partial sharing of its posi-
tive charge with donor group in chelate ring system, The
process of chelation thus increases the lipophilic nature of
central ion. This in turn favours it permeation through the
Fig. 4 Lipoprotective efficacy of cinnamaldehyde and eugenol in rat liver homogenate. Lipid peroxidation inhibition (% LPOI) was determined at
different concentrations (1.0, 2.0, 3.0 μM/ml) as described in methods. BHA was used as standard lipoprotective agent. The results are expressed
as mean ± SD of three replicates (P <0.05). Abbreviations: Cin cinnamaldehyde, Eug eugenol, BHA butylated hydroxyanisole
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lipid layer of membrane which reduces hydroxyl radical
generation at the site and thereby prevents initiation of
lipid peroxidation [43]. Positive correlations between
metal ion chelating ability and lipoprotective activity have
also been reported earlier [46].
Emergence of multiple drug resistance in human
pathogenic organisms has given momentum to search
for new antimicrobial substances from alternative sources.
Cinnamaldehyde exhibited considerable antibacterial ac-
tivity against test bacteria (Table 1). There are reports
showing appreciable killing potential in cinnamaldehyde
against other bacteria [47, 48]. Comparatively lower
activity was observed with eugenol. Cinnamaldehyde
and eugenol are major ingredients of essential oils ob-
tained from various species of genus Cinnamomum. A
critical property of antibacterial components in essential
oils is their hydrophobicity, which helps them to target
the lipid-containing bacterial cell membrane and mito-
chondria [49]. In addition, these molecules can damage
membrane proteins, deplete the proton motive force,
cause leakage of cell contents and coagulate cytoplasm
[50, 51]. Although these mechanisms might act independ-
ently, some of them could be activated as a consequence
of another, resulting in a multiplicity of mechanisms [49].
The study performed by Shang et al. on four cinnamal-
dehyde congeners having similar structures proved that
Fig. 5 Metal ion chelating activity (%) of cinnamaldehyde and eugenol. BHA and EDTA were used for comparison. The activity of samples was
represented as mean ± SD of three replicates (P <0.05). Abbreviations: Cin cinnamaldehyde, Eug eugenol, BHA butylated hydroxyanisole and EDTA
ethylenediaminetetraacetic acid
Table 1 Antibacterial activity of cinnamaldehyde and eugenol
Test bacteria 20 μM/disc 80 μM/disc 120 μM/disc Std.
antibioticCin Eug Cin Eug Cin Eug
Proteus vulgaris (MTCC 7299) 22 10 35 13 36 15 27a
Salmonella typhi (MTCC 3917) 27 10 35 13 37 16 25a
Bacillus cereus (MTCC 6840) 30 12 40 15 42 18 24b
Streptococcus mutans (MTCC 497) 30 9 32 12 36 16 18b
Bordetella bronchiseptica (MTCC 6838) 26 10 38 14 40 18 22b
Antibacterial activity was measured at three different concentrations (20, 80 and 120 μM/disc) as described in methods section. Inhibition zones (mm) are
reported as average of three replicates. Antibiotics were used as positive control. Abbreviations: Cin cinnamaldehyde, Eug eugenol, std. standard, a meropenem
(10 μg/disc), b vancomycin (30 μg/disc)
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a conjugated double bond and a long CH chain outside
the ring is responsible for better antibacterial activity of
cinnamaldehyde. However presence of the hydroxyl
group has also been shown to improve the antibacterial
activity [52]. Trans-cinnamaldehyde has been reported
to possess antimicrobial activity toward a wide range of
foodborne pathogens [53, 54]. Eugenol has been shown
to produce antibacterial effect against Salmonella typhi
by damaging cytoplasmic membrane and causes subse-
quent leakage of intracellular constituents [55].
Cancer chemotherapeutic agent can often provide pro-
longation of life, temporary relief from symptoms and
occasionally complete remission. A successful anticancer
drug should kill or incapacitate cancer cells by inducing
apoptosis in cancer cell. Toxicity caused by chemopreven-
tive agents imposes restriction on their frequent usage
and patients seek alternative methods of treatment. Hence
there is need for developing new approaches and drugs
from natural sources to treat cancer. Many important an-
ticancer drugs are derived from plant sources such as
taxol and camptothecin [38]. The free radical, especially
hydroxyl radical, has ability to add to double bonds of
DNA bases. It abstracts an H-atom from the methyl group
of thymine and each of the five carbon atoms of deoxyri-
bose at a very high rate constant resulting in permanent
modification of genetic material leading to malfunctions
of cellular process. Thus free radicals represent the first
step involved in carcinogenesis [56]. Hence radical scaven-
ging action shown by cinnamaldehyde and eugenol might
play role in inhibiting initiation of carcinogenesis.
In the study cinnamaldehyde and eugenol displayed
moderate antiproliferative activity against breast (T47D)
and lung (NCI-H322) cancer cell lines (Fig. 6) showing an-
ticancer potential which signifies their role in inhibiting
cancer progression. Drugs being used for the cancer treat-
ment follow different mechanisms of action. A number of
herbal products have been reported to induce cell cycle ar-
rest and thereby play important role in cancer prevention
and therapy [57]. Furthermore, cinnamaldehyde has also
been shown to inhibit cyclin dependent kinases (CDKs)
which are involved in cell cycle regulation [58]. Many
workers have reported cytotoxic effect of eugenol against
human osteoblast (U2OS), fibroblast (HFF) and hepatoma
(HepG2) cell lines [59, 60]. The modulation of angiogen-
esis, DNA (synthesis, transcription and translation), en-
zyme activity and microtubule inhibition remains an
important therapeutic strategy against numerous diseases,
including cancer [61]. Hence further studies are required
for understanding the mechanism of action of cinnamal-
dehyde and eugenol as pharmacological agents.
Fig. 6 Antiproliferative activity of cinnamaldehyde and eugenol against cancer cell lines. Results are expressed as % inhibition on growth of cell
lines (mean ± SD, n = 3). Abbreviations: T47D breast, NCI-H322 lung, PC-3 prostate cancer cell lines, Cin cinnamaldehyde, Eug eugenol, ACD
anticancer drugs [Mitomycin (1 μM) against breast and prostate cancer cell lines; 5-fluro uracil (5 μM) against lung cancer cell line]
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Conclusion
Cinnamaldehyde and eugenol exhibited considerable anti-
oxidants, antimicrobials and moderate cytotoxic activities.
Cinnamaldehyde showed lipo-protective and metal ion
chelating abilities while eugenol accounted for radical
scavenging and reducing activities. Cinnamaldehyde dem-
onstrated appreciable antibacterial activity as compared to
eugenol. The study will provide insight to researchers for
utilization of these compounds for food and medicinal
applications.
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